Xspray Pharma AB (publ) 6XP.SG Stock
Xspray Pharma AB (publ) Price Chart
Xspray Pharma AB (publ) 6XP.SG Financial and Trading Overview
| Xspray Pharma AB (publ) stock price | 3.47 EUR |
| Previous Close | 3.21 EUR |
| Open | 3.14 EUR |
| Bid | 3.22 EUR x 0 |
| Ask | 3.33 EUR x 0 |
| Day's Range | 3.14 - 3.19 EUR |
| 52 Week Range | 3.14 - 7.04 EUR |
| Volume | 0 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 72.57M EUR |
| Beta (5Y Monthly) | 0.908045 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.59 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6XP.SG Valuation Measures
| Enterprise Value | 113.4M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.7025863 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Xspray Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.908045 |
| 52-Week Change | -34.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.04 EUR |
| 52 Week Low | 3.14 EUR |
| 50-Day Moving Average | 4.62 EUR |
| 200-Day Moving Average | 5.09 EUR |
6XP.SG Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 22.68M |
| Float | 16.18M |
| Short Ratio | N/A |
| % Held by Insiders | 47.38% |
| % Held by Institutions | 23.83% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -16.28% |
| Return on Equity (ttm) | -26.97% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.57 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 0.3 EUR |
| Current Ratio (mrq) | 3.132 |
| Book Value Per Share (mrq) | 1.856 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Xspray Pharma AB (publ)
| Country | Germany |
| State | N/A |
| City | Solna |
| Address | Råsundavägen 12 |
| ZIP | 169 67 |
| Phone | 46 87 30 37 00 |
| Website | https://www.xspraypharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26 |
Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include XS003 for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and XS004 for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.
Q&A For Xspray Pharma AB (publ) Stock
What is a current 6XP.SG stock price?
Xspray Pharma AB (publ) 6XP.SG stock price today per share is 3.47 EUR.
How to purchase Xspray Pharma AB (publ) stock?
You can buy 6XP.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xspray Pharma AB (publ)?
The stock symbol or ticker of Xspray Pharma AB (publ) is 6XP.SG.
Which industry does the Xspray Pharma AB (publ) company belong to?
The Xspray Pharma AB (publ) industry is Biotechnology.
How many shares does Xspray Pharma AB (publ) have in circulation?
The max supply of Xspray Pharma AB (publ) shares is 31.69M.
What is Xspray Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Xspray Pharma AB (publ) PE Ratio is now.
What was Xspray Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Xspray Pharma AB (publ) EPS is -0.59 EUR over the trailing 12 months.
Which sector does the Xspray Pharma AB (publ) company belong to?
The Xspray Pharma AB (publ) sector is Healthcare.